BerganKDV Wealth Management, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
BerganKDV Wealth Management, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2023$320
+52.4%
1150.0%0.00%
Q1 2023$210
-64.0%
1150.0%0.00%
Q4 2022$583
-41.7%
1150.0%0.00%
Q3 2022$1,0001150.0%0.00%
Q2 2022$0
-100.0%
1150.0%0.00%
Q1 2022$1,0000.0%1150.0%0.00%
Q4 2021$1,0000.0%1150.0%0.00%
Q3 2021$1,000
-50.0%
1150.0%0.00%
Q2 2021$2,0001150.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders